Publication Date:
2013-05-24
Description:
Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals Cell Death and Disease 4, e640 (May 2013). doi:10.1038/cddis.2013.166 Authors: H-M Yun, J H Oh, J-H Shim, J O Ban, K-R Park, J-H Kim, D H Lee, J-W Kang, Y H Park, D Yu, Y Kim, S B Han, D-Y Yoon & J T Hong
Keywords:
IL-32βlymphocytesNF-κBSTAT3tumor growth
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink